Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Other ASCO 2018 Highlights – It’s Not All IO

May 18 2018

• By Emily Hayes and Jessica Merrill

Digital illustration of Cancer cell in colour background

Related Content

Agios' IDH Inhibitors Show Their Mettle At ASH

Dec 12 2017

Loxo's Larotrectinib Requires Paradigm-Change In Clinical Practice

Jun 05 2017

Pfizer drug fails in two Phase III lung cancer studies

Jan 28 2014

Rolontis Leads Hanmi’s Global Ambitions As ADVANCE Phase III Endpoint Met

Feb 09 2018

More Deals Like Loxo On The Cards As Bayer Ups Ante In Oncology

Mar 06 2018

Related Companies

Pfizer Inc.

AstraZeneca PLC

G1 Therapeutics Inc.

Roche Holding AG

Loxo Oncology at Lilly

Bayer AG

Blueprint Medicines Corporation

Novartis AG

Eli Lilly and Company

Spectrum Pharmaceuticals, Inc.

Hanmi Pharmaceutical Co., Ltd.

Agios Pharmaceuticals, Inc.

Bristol Myers Squibb Company

Additional Topics

Clinical Trials Research & Development Cancer BioPharmaceutical

More from Clinical Trials

More from R&D

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window